Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics
Medtronic plc. Ordinary Shares (MDT)
Today's Latest Price: $111.84 USD
Updated Oct 22 4:00pm
Add MDT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 142 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
MDT Stock Summary
- MDT has a higher market value than 98.89% of US stocks; more precisely, its current market capitalization is $146,828,632,959.
- MDT's went public 34.83 years ago, making it older than 92.9% of listed US stocks we're tracking.
- In terms of volatility of its share price, MDT is more volatile than only 7.39% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Medtronic plc are DHR, TMUS, UNP, NVO, and SNY.
- Visit MDT's SEC page to see the company's official filings. To visit the company's web site, go to www.medtronic.com.
MDT Stock Price Chart Interactive Chart >
MDT Price/Volume Stats
| Current price | $111.84 | 52-week high | $122.15 |
| Prev. close | $109.23 | 52-week low | $72.13 |
| Day low | $109.07 | Volume | 3,997,869 |
| Day high | $112.20 | Avg. volume | 5,788,134 |
| 50-day MA | $105.22 | Dividend yield | 2.12% |
| 200-day MA | $101.02 | Market Cap | 150.34B |
Medtronic plc. Ordinary Shares (MDT) Company Bio
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.
MDT Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $111.84 | $35.88 | -67% |
Below please find a table outlining a discounted cash flow forecast for MDT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Medtronic plc ranked in the 22th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:
- MDT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 25.52% of tickers in our DCF set.
- Medtronic plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 8. This value is greater than merely 19.06% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -68% |
| 1% | -67% |
| 2% | -67% |
| 3% | -67% |
| 4% | -66% |
| 5% | -66% |
Want more companies with a valuation profile/forecast similar to that of Medtronic plc? See BAX, GMED, OFIX, SRDX, and ABT.
Loading social stream, please wait...